GENELUX Corp financial data

Symbol
GNLX on Nasdaq
Industry
Pharmaceutical Preparations
Location
2625 Townsgate Road, Suite 230, Westlake Village, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 474 % +66.4%
Debt-to-equity 29.2 % -49.4%
Return On Equity -107 % +35.6%
Return On Assets -82.5 % +21.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 34.6M shares +28.8%
Common Stock, Shares, Outstanding 34.7M shares +29.6%
Entity Public Float 57.9M USD -91.4%
Common Stock, Value, Issued 35K USD +29.6%
Weighted Average Number of Shares Outstanding, Basic 31.5M shares +28.7%
Weighted Average Number of Shares Outstanding, Diluted 31.5M shares +28.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 8K USD -95.3%
Research and Development Expense 19M USD +48.8%
General and Administrative Expense 12.7M USD +9.84%
Operating Income (Loss) -31.7M USD -31.2%
Nonoperating Income (Expense) 1.83M USD +230%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -5.35M USD -189%
Net Income (Loss) Attributable to Parent -29.9M USD -5.56%
Earnings Per Share, Basic -0.95 USD/shares +18.1%
Earnings Per Share, Diluted -0.95 USD/shares +18.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.57M USD -9.06%
Cash, Cash Equivalents, and Short-term Investments 30.9M USD +33.2%
Assets, Current 31.5M USD +30.3%
Property, Plant and Equipment, Net 1.32M USD +12.5%
Operating Lease, Right-of-Use Asset 1.76M USD -27.5%
Other Assets, Noncurrent 92K USD 0%
Assets 34.7M USD +24.5%
Employee-related Liabilities, Current 2.68M USD
Liabilities, Current 6.9M USD +5.33%
Operating Lease, Liability, Noncurrent 1.54M USD -17.5%
Liabilities 8.44M USD +0.26%
Accumulated Other Comprehensive Income (Loss), Net of Tax 64K USD +357%
Retained Earnings (Accumulated Deficit) -251M USD -13.5%
Stockholders' Equity Attributable to Parent 26.3M USD +34.9%
Liabilities and Equity 34.7M USD +24.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.35M USD +5.14%
Net Cash Provided by (Used in) Financing Activities 688K USD -95.3%
Net Cash Provided by (Used in) Investing Activities -1.69M USD -1451%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 34.7M shares +29.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.36M USD -154%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 8.57M USD -9.06%
Interest Paid, Excluding Capitalized Interest, Operating Activities 50K USD -65.8%
Deferred Tax Assets, Valuation Allowance 67M USD +8.34%
Deferred Tax Assets, Gross 67M USD +8.34%
Operating Lease, Liability 1.87M USD -25.8%
Depreciation 84K USD -38.2%
Payments to Acquire Property, Plant, and Equipment 30K USD -72.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -29.8M USD -5.42%
Property, Plant and Equipment, Gross 5M USD +8.25%
Operating Lease, Liability, Current 329K USD -49.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 362K USD +9.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 329K USD -49.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 333K USD -8.01%
Deferred Tax Assets, Operating Loss Carryforwards 70M USD +313380%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 276K USD -16.6%
Operating Lease, Payments 148K USD +29.8%
Additional Paid in Capital 278M USD +15.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 71.4M USD +8.56%
Share-based Payment Arrangement, Expense 1.49M USD +556%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%